Terrance P. Coyne

Insider Reports History

Location
New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terrance P. Coyne:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP & CFO LP interests in RPI US Partners 2019, LP 483,942 $173,444,812 $358.40 06 Aug 2025 By TPC RP, LLC
Royalty Pharma plc EVP & CFO LP interests in RPI US Partners 2019, LP 117,526 $42,121,318 $358.40 06 Aug 2025 By TPC RP 2021, LLC
Royalty Pharma plc EVP & CFO LP interests in RPI US Partners 2019, LP 43,350 $15,536,640 $358.40 08 Aug 2025 By TPC ICAI, LLC
Royalty Pharma plc EVP & CFO Class A Ordinary Shares 98,748 $4,642,587 $47.01 02 Mar 2026 By TPC RP 2021, LLC
Royalty Pharma plc EVP & CFO Class A Ordinary Shares 45,761 $2,151,421 $47.01 02 Mar 2026 TPC RP EPA1 LLC
Royalty Pharma plc EVP & CFO Class A Ordinary Shares 24,170 $1,023,841 $42.36 02 Mar 2026 By Spouse's IRA
Royalty Pharma plc EVP & CFO Class A Ordinary Shares 23,270 $985,717 $42.36 02 Mar 2026 By IRA
Royalty Pharma plc EVP & CFO Class A Ordinary Shares 1,500 $63,540 $42.36 02 Mar 2026 Direct
Royalty Pharma plc EVP & CFO Class A Ordinary Shares 1,450 $61,422 $42.36 02 Mar 2026 By Spouse
Royalty Pharma plc EVP & CFO Class E Ordinary Shares 1,807,277 16 May 2025 Indirect

Insider Reports Filed by Terrance P. Coyne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPRX Royalty Pharma plc 02 Mar 2026 4 -$1,627,534 4 EVP & CFO 04 Mar 2026, 17:11
RPRX Royalty Pharma plc 23 Feb 2026 2 -$1,576,606 4 EVP & CFO 25 Feb 2026, 16:08
RPRX Royalty Pharma plc 11 Feb 2026 1 $0 4 EVP & CFO 13 Feb 2026, 16:03
RPRX Royalty Pharma plc 02 Feb 2026 6 -$10,360,814 4 EVP & CFO 04 Feb 2026, 17:07
RPRX Royalty Pharma plc 20 Jan 2026 2 -$2,737,940 4 EVP & CFO 23 Jan 2026, 16:48
RPRX Royalty Pharma plc 02 Jan 2026 2 -$2,673,041 4 EVP & CFO 06 Jan 2026, 16:18
RPRX Royalty Pharma plc 15 Dec 2025 2 -$2,669,172 4 EVP & CFO 17 Dec 2025, 17:39
RPRX Royalty Pharma plc 01 Dec 2025 2 -$2,773,956 4 EVP & CFO 03 Dec 2025, 17:11
RPRX Royalty Pharma plc 24 Nov 2025 4 -$2,682,505 4 EVP & CFO 26 Nov 2025, 17:01
RPRX Royalty Pharma plc 17 Nov 2025 2 -$2,735,329 4 EVP & CFO 19 Nov 2025, 16:53
RPRX Royalty Pharma plc 05 Nov 2025 1 $0 4 EVP & CFO 07 Nov 2025, 16:18
RPRX Royalty Pharma plc 06 Aug 2025 2 $0 4 EVP & CFO 08 Aug 2025, 16:58
RPRX Royalty Pharma plc 16 May 2025 1 $0 4 EVP & CFO 20 May 2025, 16:52
RPRX Royalty Pharma plc 08 May 2025 1 $0 4 EVP & CFO 09 May 2025, 17:10
RPRX Royalty Pharma plc 12 Aug 2024 1 $0 4 EVP & CFO 12 Aug 2024, 19:20
RPRX Royalty Pharma plc 09 Aug 2023 2 -$2,305,028 4 EVP & CFO 11 Aug 2023, 17:00
RPRX Royalty Pharma plc 08 Aug 2023 1 $0 4 EVP & CFO 08 Aug 2023, 17:37
RPRX Royalty Pharma plc 12 Jul 2023 2 -$2,325,214 4 EVP & CFO 14 Jul 2023, 18:09
RPRX Royalty Pharma plc 08 Nov 2022 1 -$1,065,013 4 EVP & CFO 10 Nov 2022, 16:04
RPRX Royalty Pharma plc 02 Nov 2022 1 -$236,846 4 EVP & CFO 04 Nov 2022, 19:16
RPRX Royalty Pharma plc 01 Aug 2022 1 -$1,295,727 4 EVP & CFO 03 Aug 2022, 19:12
RPRX Royalty Pharma plc 07 May 2021 2 $0 4 EVP & CFO 11 May 2021, 21:05